T1	PROC 46 66	Análisis comparativo
#1	AnnotatorNotes T1	C1579762; comparative study research; Research Activity
T2	CHEM 84 100	FSH recombinante
#2	AnnotatorNotes T2	C0724588; Recombinant Follicle Stimulating Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T3	PROC 136 156	donación de ovocitos
#3	AnnotatorNotes T3	C0242813; Oocyte Donation; Therapeutic or Preventive Procedure
T4	CHEM 251 261	biosimilar
#4	AnnotatorNotes T4	C4045974; Biosimilars; Pharmacologic Substance
T5	ANAT 148 156	ovocitos
#5	AnnotatorNotes T5	C0029045; Oocytes; Cell
T6	PROC 179 217	Ensayo clínico prospectivo y aleatorio
#6	AnnotatorNotes T6	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T7	PROC 223 244	comprobar la eficacia
#7	AnnotatorNotes T7	C1707887; Efficacy Study; Research Activity
T8	CHEM 296 308	FSH urinaria
#8	AnnotatorNotes T8	C0524639; Human FSH, Urinary; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T9	PROC 338 358	donación de ovocitos
#9	AnnotatorNotes T9	C0242813; Oocyte Donation; Therapeutic or Preventive Procedure
T10	ANAT 350 358	ovocitos
#10	AnnotatorNotes T10	C0029045; Oocytes; Cell
T11	CHEM 457 467	biosimilar
#11	AnnotatorNotes T11	C4045974; Biosimilars; Pharmacologic Substance
T12	PROC 394 416	determinar la eficacia
#12	AnnotatorNotes T12	C1707887; Efficacy Study; Research Activity
T13	PROC 548 570	determinar la eficacia
#13	AnnotatorNotes T13	C1707887; Efficacy Study; Research Activity
T14	PROC 646 666	donación de ovocitos
#14	AnnotatorNotes T14	C0242813; Oocyte Donation; Therapeutic or Preventive Procedure
T15	ANAT 658 666	ovocitos
#15	AnnotatorNotes T15	C0029045; Oocytes; Cell
T16	CHEM 577 587	biosimilar
#16	AnnotatorNotes T16	C4045974; Biosimilars; Pharmacologic Substance
T17	CHEM 815 829	gonadotropinas
#17	AnnotatorNotes T17	C0018061; Gonadotropins; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T18	ANAT 907 915	Ovocitos
#18	AnnotatorNotes T18	C0029045; Oocytes; Cell
T19	CHEM 310 318	Fostipur
T20	ANAT 959 977	folículos antrales
#19	AnnotatorNotes T20	C0600225; Graafian Follicle; Body Part, Organ, or Organ Component
T21	ANAT 996 1014	folículos antrales
#20	AnnotatorNotes T21	C0600225; Graafian Follicle; Body Part, Organ, or Organ Component
T22	ANAT 1019 1025	ovario
#21	AnnotatorNotes T22	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T23	PROC 941 977	recuento basal de folículos antrales
T24	PROC 1119 1154	tratamiento de estimulación ovárica
#22	AnnotatorNotes T24	C0949385; Ovarian Stimulation; Therapeutic or Preventive Procedure
T25	DISO 1170 1186	quistes ováricos
#23	AnnotatorNotes T25	C0029927; Ovarian Cysts; Disease or Syndrome
T26	PROC 1241 1253	estimulación
#24	AnnotatorNotes T26	C1292856; Stimulation procedure; Therapeutic or Preventive Procedure
T27	DISO 1335 1352	Hipersensibilidad
#25	AnnotatorNotes T27	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T28	CHEM 1361 1373	medicamentos
#26	AnnotatorNotes T28	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T29	CHEM 73 83	biosimilar
#27	AnnotatorNotes T29	C4045974; Biosimilars; Pharmacologic Substance
T30	CHEM 105 117	FSH urinaria
#28	AnnotatorNotes T30	C0524639; Human FSH, Urinary; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T31	CHEM 265 281	FSH recombinante
#29	AnnotatorNotes T31	C0724588; Recombinant Follicle Stimulating Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T32	CHEM 283 290	Bemfola
T33	CHEM 474 490	FSH recombinante
#30	AnnotatorNotes T33	C0724588; Recombinant Follicle Stimulating Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T34	CHEM 594 610	FSH recombinante
#31	AnnotatorNotes T34	C0724588; Recombinant Follicle Stimulating Hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T35	CHEM 615 627	FSH urinaria
#32	AnnotatorNotes T35	C0524639; Human FSH, Urinary; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T36	PROC 895 915	Donación de Ovocitos
#33	AnnotatorNotes T36	C0242813; Oocyte Donation; Therapeutic or Preventive Procedure
T37	DISO 1042 1052	patologías
#34	AnnotatorNotes T37	C0677042; Pathology processes; Pathologic Function
T38	ANAT 1147 1154	ovárica
#35	AnnotatorNotes T38	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T39	ANAT 1178 1186	ováricos
#36	AnnotatorNotes T39	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T40	PROC 1303 1306	IMC
#37	AnnotatorNotes T40	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T41	PROC 1319 1322	IMC
#38	AnnotatorNotes T41	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T42	Date 13 17	2015
T43	LIVB 694 703	Pacientes
#39	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Age 710 720	18-35 años
T46	LIVB 925 933	Paciente
#40	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 1028 1037	Pacientes
#41	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 1081 1093	investigador
#42	AnnotatorNotes T48	C0035173; Research Personnel; Professional or Occupational Group
T50	LIVB 1204 1216	investigador
#43	AnnotatorNotes T50	C0035173; Research Personnel; Professional or Occupational Group
T54	LIVB 1293 1300	donante
#44	AnnotatorNotes T54	C2191327; donor of organ or tissue; Patient or Disabled Group
T55	ANAT 440 450	ovocitaria
#45	AnnotatorNotes T55	C0029045; Oocytes; Cell
T45	LIVB 780 788	Donantes
#46	AnnotatorNotes T45	C2191327; donor of organ or tissue; Patient or Disabled Group
A1	Status T27 History_of
T49	Spec_cue 1095 1101	puedan
T51	CONC 1102 1112	interferir
A2	Assertion T51 Speculated
#47	AnnotatorNotes T51	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T49 Arg2:T51	
T52	Spec_cue 1217 1223	puedan
T53	CONC 1224 1234	interferir
A3	Assertion T53 Speculated
#48	AnnotatorNotes T53	C0521102; Interferes with; Functional Concept
R2	Speculation Arg1:T52 Arg2:T53	
T56	Spec_cue 1256 1262	puedan
T57	Observation 1278 1284	riesgo
A4	Assertion T57 Speculated
R3	Speculation Arg1:T56 Arg2:T57	
R4	Experiences Arg1:T54 Arg2:T57	
R13	Has_Age Arg1:T43 Arg2:T44	
T58	Observation 725 788	cumplan con los criterios de entrada en el Programa de Donantes
#49	AnnotatorNotes T58	C2585138; Eligible to be a donor; Finding
R15	Experiences Arg1:T43 Arg2:T17	
R16	Before Arg1:T58 Arg2:T17	
R17	Experiences Arg1:T45 Arg2:T17	
T59	Result_or_Value 978 990	>20 en total
R19	Has_Result_or_Value Arg1:T23 Arg2:T59	
T60	Result_or_Value 993 1025	<6 folículos antrales por ovario
R20	Has_Result_or_Value Arg1:T23 Arg2:T60	
R21	Experiences Arg1:T46 Arg2:T23	
R22	Location_of Arg1:T20 Arg2:T23	
R23	Location_of Arg1:T21 Arg2:T23	
R24	Location_of Arg1:T22 Arg2:T23	
#50	AnnotatorNotes T23	C3273281; Antral follicle count; Diagnostic Procedure (?)
R25	Experiences Arg1:T47 Arg2:T37	
R27	Before Arg1:T37 Arg2:T24	
R28	Location_of Arg1:T38 Arg2:T24	
R29	Experiences Arg1:T47 Arg2:T24	
R30	Location_of Arg1:T39 Arg2:T25	
R33	Before Arg1:T25 Arg2:T57	
R34	Experiences Arg1:T54 Arg2:T26	
R35	Experiences Arg1:T54 Arg2:T25	
T61	Result_or_Value 1307 1316	<18 kg/m2
T62	Result_or_Value 1323 1332	>30 kg/m2
R36	Has_Result_or_Value Arg1:T41 Arg2:T62	
R37	Has_Result_or_Value Arg1:T40 Arg2:T61	
R38	Causes Arg1:T28 Arg2:T27	
T63	Quantifier_or_Qualifier 1374 1396	con estructura similar
R39	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T63	
T64	Quantifier_or_Qualifier 1353 1358	grave
#51	AnnotatorNotes T64	C1547227; Severe - Severity of Illness Code; Intellectual Product
R40	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T64	
#52	AnnotatorNotes T57	C0559571; At risk; Finding
R5	Has_Age Arg1:T45 Arg2:T44	
A5	Experiencer T43 Patient
A6	Experiencer T45 Patient
A7	Experiencer T46 Patient
A8	Experiencer T47 Patient
A9	Experiencer T48 Other
A10	Experiencer T50 Other
A11	Experiencer T54 Patient
A12	Status T17 Future
